Levetiracetam: Drug Profile

What is Levetiracetam?

Levetiracetam is an antiepileptic medication belonging to the pyrrolidone class of anticonvulsants. It is primarily used to prevent and control seizures in people with epilepsy and certain seizure disorders. Unlike older anticonvulsants, levetiracetam has a unique mechanism of action and is generally well-tolerated by most patients.

Uses

Levetiracetam is FDA-approved for several seizure-related conditions:

• Partial-onset seizures: Used as adjunctive therapy in adults and children 4 years and older with focal seizures, with or without secondary generalization
• Myoclonic seizures: Approved as adjunctive treatment for myoclonic seizures in adults and adolescents 12 years and older with juvenile myoclonic epilepsy
• Primary generalized tonic-clonic seizures: Used as additional therapy for generalized tonic-clonic seizures in adults and children 6 years and older
• Monotherapy for partial seizures: Can be used as single-drug treatment for partial-onset seizures in patients 16 years and older
• Status epilepticus: Sometimes used off-label as an alternative treatment for prolonged seizures when first-line medications are ineffective

How it works

Levetiracetam works by binding to a specific protein called SV2A (synaptic vesicle protein 2A) in nerve terminals throughout the brain. This binding appears to modulate neurotransmitter release and reduce abnormal electrical activity that leads to seizures. Unlike many other antiepileptic drugs, levetiracetam does not significantly affect sodium channels, calcium channels, or GABA receptors, making its mechanism relatively unique among seizure medications.

Side effects

Common side effects include:

Submit Your Paper

• Drowsiness and fatigue
• Dizziness
• Behavioral changes and irritability
• Headache
• Loss of appetite
• Coordination problems
• Nasal congestion
• Infection-related symptoms

Serious side effects requiring immediate medical attention:

• Severe mood changes, depression, or suicidal thoughts
• Aggressive behavior or psychosis
• Severe allergic reactions with rash, swelling, or difficulty breathing
• Severe dizziness or loss of coordination leading to falls
• Signs of low blood cell counts (unusual bruising, frequent infections)

Warnings and precautions

• Mental health monitoring: All antiepileptic drugs, including levetiracetam, carry an increased risk of suicidal thoughts and behavior. Patients should be monitored closely for mood changes, depression, or unusual behavioral changes.
• Kidney function: Dose adjustments are necessary for patients with reduced kidney function, as the drug is primarily eliminated through the kidneys.
• Pregnancy considerations: Levetiracetam is classified as pregnancy category C. While it may be safer than some other antiepileptic drugs, the benefits and risks should be carefully weighed with a healthcare provider.
• Gradual discontinuation: Stopping levetiracetam suddenly can trigger breakthrough seizures or status epilepticus. The medication should always be tapered gradually under medical supervision.
• Elderly patients: Older adults may be more sensitive to side effects, particularly drowsiness and coordination problems, increasing fall risk.

Interactions

• Other central nervous system depressants: Alcohol, benzodiazepines, and opioids may increase drowsiness and sedation when combined with levetiracetam
• Other antiepileptic drugs: While levetiracetam has fewer drug interactions than many seizure medications, combining multiple anticonvulsants may increase overall side effects
• Metformin: May have reduced elimination when used with levetiracetam, though this interaction is generally not clinically significant
• Probenecid: Can increase levetiracetam blood levels by reducing kidney elimination
• Oral contraceptives: Unlike many antiepileptic drugs, levetiracetam does not reduce the effectiveness of birth control pills
• Warfarin: Generally no significant interaction, but monitoring may be increased when starting or stopping levetiracetam
• Digoxin: No significant interaction reported, making levetiracetam safer for patients with heart conditions requiring digoxin
• Herbal supplements: St. John’s wort and other enzyme-inducing herbs are less likely to interact with levetiracetam compared to other antiepileptic medications

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing ranges from 500 mg to 1,500 mg twice daily, with most patients starting at 500 mg twice daily. The dose is usually increased gradually every 2-4 weeks based on seizure control and tolerability. Maximum recommended dose is typically 3,000 mg per day (1,500 mg twice daily). Patients with kidney impairment require dose reductions based on creatinine clearance. All dosage adjustments should be made only under the guidance of a qualified healthcare provider who can assess individual patient factors and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).